Výsledky vyhledávání - "Greskovich JF"

Akademický článek

Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and Neck.

Autor: Domb C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Smile TD; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Reddy C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Campbell SR; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Canavan JF; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Joshi NP; Department of Radiation Oncology, Rush University Cancer Center, Chicago, IL, U.S.A., Greskovich JF; Department of Radiation Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, U.S.A., Chute DJ; Department of Pathology, Cleveland Clinic, Cleveland, OH, U.S.A., Burkey BB; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Ku LA; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Lamarre E; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Lorenz RR; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Prendes B; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Scharpf J; Head and Neck Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Schwartzman L; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, U.S.A., Geiger JL; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, U.S.A., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.A., Fleming CW; Department of Radiation Oncology, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, U.S.A.; cfleming654@gmail.com.

Publikováno v: Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 4995-5000.

Zobrazit plný text záznamu

Akademický článek

Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.

Autor: Fleming CW; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address: fleminc@ccf.org., Ward MC; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Joshi NP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Greskovich JF Jr; Department of Radiation Oncology, Cleveland Clinic Florida, Weston, FL, United States., Rybicki L; Department of Quantitative Health Sciences, Cleveland Clinic Learner Research Institute, Cleveland, OH, United States., Xiong D; Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States., Contrera K; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Chute DJ; Department of Pathology, Cleveland Clinic, Cleveland, OH, United States., Milas ZL; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Frenkel CH; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Brickman DS; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Carrizosa DR; Department of Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Ku J; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Prendes B; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Lamarre E; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Lorenz RR; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Scharpf J; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Burkey BB; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, OH, United States., Schwartzman L; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Geiger JL; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Adelstein DJ; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.

Publikováno v: Oral oncology [Oral Oncol] 2021 Jan; Vol. 112, pp. 105046. Date of Electronic Publication: 2020 Oct 28.

Zobrazit plný text záznamu

Akademický článek

Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation Therapy.

Autor: Sharrett JM; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Ward MC; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Murray E; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Scharpf J; Taussig Cancer Institute; and the Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Lamarre ED; Taussig Cancer Institute; and the Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Prendes BL; Taussig Cancer Institute; and the Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Lorenz RR; Taussig Cancer Institute; and the Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Burkey BB; Taussig Cancer Institute; and the Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Koyfman SA; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Woody NM; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Greskovich JF; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Adelstein DJ; Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Geiger JL; Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A., Joshi NP; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.

Publikováno v: The Laryngoscope [Laryngoscope] 2020 Oct; Vol. 130 (10), pp. 2372-2377. Date of Electronic Publication: 2019 Nov 13.

Zobrazit plný text záznamu

Akademický článek

Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.

Autor: Broughman JR; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Xiong DD; Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Moeller BJ; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Contrera KJ; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Prendes BL; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Lamarre ED; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Ku JA; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Burkey BB; Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Woody NM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Joshi NP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Adelstein DJ; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Geiger JL; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Frenkel CH; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Milas ZL; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Brickman DS; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Sumrall AL; Department of Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Carrizosa DR; Department of Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Greskovich JF; Department of Radiation Oncology, Cleveland Clinic Florida, Weston, Florida., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Ward MC; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.

Publikováno v: Cancer [Cancer] 2020 Jun 15; Vol. 126 (12), pp. 2784-2790. Date of Electronic Publication: 2020 Mar 13.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání